OTCs could be ‘profit rockets’ for pharmacies, says Maxwellia boss

exclusive
Profit rockets
“OTC has been overlooked a little bit” in the development of Pharmacy First
James Stent

Read more by James Stent

James Stent joined C+D as a digital reporter in May 2023 from the South African human rights news agency GroundUp, where he was senior reporter and consultant editor.

Latest from News

More from Business